GBI Research Market Research Reports





RSS Sort By :
TITLE Price Buy Now More options

Type 2 Diabetes Mellitus (T2DM) is a metabolic disease characterized by chronic hyperglycemia (high blood glucose levels). Global prevalence has risen rapidly in the past several decades, particularly in line with obesity. This has been attributed...

$ 4995


The oncology therapy area comprises a large and diverse range of indications, encompassing virtually all sites and tissues in the human body. These indications are the leading cause of death in economically developed countries and the second-leadi...

$ 6995


Multiple Myeloma (MM) is a hematological malignancy characterized by the proliferation of plasma cells in the bone marrow. It is the second-most frequently diagnosed hematological malignancy, with an annual prevalence in the US of about 45,000. Th...

$ 4995


Hypertension is a chronic medical condition characterized by elevated blood pressure in the arteries. It affected an estimated 517 million people in 2014, a figure that will grow at a Compound Annual Growth Rate (CAGR) of 1.2% to 561 million in 20...

$ 4995


Pancreatic cancer is the 12th most common cancer globally, and the fourth most fatal, with a mortality rate of 10.9 deaths per 100,000 people per year. The poor prognosis of pancreatic cancer patients has highlighted a significant need for new and...

$ 6995


Highly Innovative and Diverse PipelineThe Duchenne Muscular Dystrophy (DMD) and Becker Muscular Dystrophy (BMD) pipeline consists of 84 molecules across all stages of development. GBI Research's analysis revealed a high...

$ 6995


Large and Innovative PipelineAnalysis has confirmed the asthma pipeline to be highly active, with 252 products in active development across all stages. The range of mechanisms of action employed by...

$ 6995


GBI Research, the leading business intelligence provider, has released its latest research, Psoriasis Therapeutics in Asia-Pacific Markets to 2021: Advent of Novel Biologics and Expanding Treatment Pool to Drive Growth, which provides ...

$ 4995


GBI Research, the leading business intelligence provider, has released its latest research, Rheumatoid Arthritis Therapeutics in Asia-Pacific Markets to 2021 - Novel IL-6 and JAK Inhibitors to Stimulate Moderate Growth Despite Brand Erosion ...

$ 4995


GBI Research's report, MRI Systems Market to 2020 - Focus on Patient Comfort and Operational Efficiency, with Growth Driven by Developing Economies discusses the market, competitive landscape, and trends for three MRI systems marke...

$ 3500


GBI Research's report, Market Digest: Multiparameter Patient Monitoring Devices 2006 to 2020 - Asia-Pacific provides quantitative analysis of the four multiparameter patient monitoring devices market segments: high acuity monitors,...

$ 1750


GBI Research's report, Market Digest: Ultrasound Systems Market 2006 to 2020 - Americas provides quantitative analysis of the two ultrasound systems market segments: stand-alone systems and portable systems. The analysis includes m...

$ 1750


GBI Research's report, Market Digest: Ultrasound Systems Market 2006 to 2020 - Asia-Pacific provides quantitative analysis of the two ultrasound systems market segments: stand-alone systems and portable systems. The analysis includ...

$ 1750


GBI Research's report, Market Digest: Ultrasound Systems Market 2006 to 2020 - Europe provides quantitative analysis of the two ultrasound systems market segments: stand-alone systems and portable systems. The analysis includes mar...

$ 1750


GBI Research, a leading business intelligence provider, has released its latest research report, Asthma Therapeutics in Major Developed Markets to 2020 - Personalized Treatment for Severe Asthma to Drive Market Growth despite Patent...

$ 4995


GBI Research's report, Market Digest: Aesthetic Lasers and Energy Devices Market 2006 to 2020 - Americas provides quantitative analysis of the three aesthetic lasers and energy devices market segments: minimally invasive body conto...

$ 1750


Large and Innovative PipelineThe active pain pipeline is populated by 796 products across all stages of development, which exhibit a highly diverse range of molecular targets. GBI Research's analyses identified 122 firs...

$ 6995


GBI Research, a leading business intelligence provider, has released its latest research report, Ovarian Cancer Therapeutics in Asia-Pacific Markets to 2020 Off-patent Chemo-regimens to Retain Dominance Despite New Launches...

$ 4995


GBI Research, the leading business intelligence provider, has released its latest research, Colorectal Cancer Therapeutics in Major Developed Markets to 2020 Increased Uptake of High Priced Drugs to Offset the Impact of Generics, which...

$ 4995


An Extensive Developmental Pipeline, but Limited First in Class InnovationThe antibiotics pipeline is very active, with 741 products in development. Of these, the majority (85%) are at the Discovery or Preclinical stages an...

$ 6995

Live Chat Support
Connect With Us
Email: sales@reportsandreports.com Call : + 1 888 391 5441
Subscription Option

Use our subscription option and keep yourself updated about the latest from GBI Research. We have market research reports of all sectors covered by the GBI Research; you can access and utilize them at economical budgets.

More about our Subscription option
Email Alerts

Get Email alerts about market research reports from industries and publishers of your interest: